Clinical Trial Update: A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 study evaluating MILR1444A to prevent allergen-induced airway obstruction in adults with mild allergic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• MILR1444A

Snippet

Sponsor: Genentech, Inc. | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED